Skip to content
★ Sign in to follow
Medley,Inc. logo

Medley,Inc. Stock: price and insider trades · Japan

株式会社メドレー

JP·Mcap JP¥70.5BHealth Care

No insider purchase over the last 90 days. The latest, by Polar Capital LLP, was filed 09 Nov 2021.

Medley,Inc.: what insiders have been doing

Medley,Inc. is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). Between 10 November 2025 and 10 November 2026, 2 insiders published 5 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Across the 3,236 companies tracked on its exchange, the median is 3 filings; at 5 filings, this issuer sits above that mark. Since 2021, the database holds 3 purchases and no sales by insiders of the company.

No insider has bought Medley,Inc. shares on the open market in the past twelve months. Between a trade and the moment it shows up on EDINET (Japan FSA), the median delay is 6 days. That lag is the time during which only the insider knows about the trade.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.

Insider Decl.
47
Thresholds
n/a
Buy Volume
€8M
3 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 09 Nov 2021 · 1827 days ago · €8.1M
    +21.5%
    Entry JP¥3,005 · Close at T+365 JP¥3,650

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,519 of 26,911 companies
49.2
score / 100
Value
43
Quality
56
FCF yld4.2%
Earn yld1.4%
EV/EBITDA17.3x
ROE11%
Gross mgn63%
Net mgn2.7%
Debt/EBITDA3.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

JP¥2,334
Analyst consensus
4 analysts
1.80/5
JP¥2,890Target JP¥3,430(+47%)JP¥4,430
Income statement
RevenueJP¥36.8B
Gross profitJP¥23.2B63% margin
EBITDAJP¥5B14% margin
Net incomeJP¥975M4.5% margin
Valuation
PER (trailing)38.4x
P/Book4.7x
Beta0.84
Balance sheet & cash
Market capJP¥70.5B
Total debtJP¥16.1B
Free Cash FlowJP¥3B
Debt / Equity126%
Profitability & ownership
ROE11.1%
ROA4.2%
% insiders30.3%
% institutions45.0%
Last declaration on 4 March 2026
Declarations47 total

25 of 47 declarations

About Medley,Inc.

Medley, Inc. is a Japanese company operating in the healthcare and pharmaceutical sector. It focuses on developing digital solutions to enhance healthcare services.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations